William Blair Investment Management LLC Grows Stake in Avanos Medical, Inc. (NYSE:AVNS)

William Blair Investment Management LLC grew its holdings in shares of Avanos Medical, Inc. (NYSE:AVNS - Free Report) by 2.1% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,406,210 shares of the company's stock after buying an additional 28,608 shares during the period. William Blair Investment Management LLC owned 3.06% of Avanos Medical worth $22,387,000 as of its most recent SEC filing.

Other hedge funds have also recently made changes to their positions in the company. Illinois Municipal Retirement Fund grew its stake in Avanos Medical by 3.1% in the fourth quarter. Illinois Municipal Retirement Fund now owns 25,236 shares of the company's stock worth $402,000 after purchasing an additional 748 shares during the period. KBC Group NV grew its stake in Avanos Medical by 63.0% in the third quarter. KBC Group NV now owns 2,833 shares of the company's stock worth $68,000 after purchasing an additional 1,095 shares during the period. Quarry LP purchased a new stake in Avanos Medical in the third quarter worth $42,000. Foundry Partners LLC grew its stake in Avanos Medical by 1.1% in the third quarter. Foundry Partners LLC now owns 163,030 shares of the company's stock worth $3,918,000 after purchasing an additional 1,800 shares during the period. Finally, US Bancorp DE grew its stake in Avanos Medical by 18.0% in the fourth quarter. US Bancorp DE now owns 14,093 shares of the company's stock worth $224,000 after purchasing an additional 2,147 shares during the period. 95.17% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Avanos Medical

In other news, SVP Kerr Holbrook sold 7,000 shares of the company's stock in a transaction on Thursday, March 6th. The stock was sold at an average price of $15.25, for a total transaction of $106,750.00. Following the transaction, the senior vice president now directly owns 82,047 shares of the company's stock, valued at $1,251,216.75. This represents a 7.86 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Insiders own 3.94% of the company's stock.

Remove Ads

Avanos Medical Stock Down 0.6 %

Shares of NYSE AVNS traded down $0.10 during trading on Friday, reaching $14.67. The company had a trading volume of 1,547,734 shares, compared to its average volume of 293,182. Avanos Medical, Inc. has a 12-month low of $14.25 and a 12-month high of $25.36. The stock has a market cap of $675.05 million, a PE ratio of 43.16 and a beta of 1.17. The business's 50-day moving average is $15.83 and its 200 day moving average is $18.72. The company has a quick ratio of 1.46, a current ratio of 2.22 and a debt-to-equity ratio of 0.12.

Avanos Medical (NYSE:AVNS - Get Free Report) last released its earnings results on Wednesday, February 26th. The company reported $0.43 EPS for the quarter, topping analysts' consensus estimates of $0.40 by $0.03. Avanos Medical had a return on equity of 4.70% and a net margin of 2.30%. The firm had revenue of $179.60 million for the quarter, compared to analysts' expectations of $177.23 million. As a group, equities analysts forecast that Avanos Medical, Inc. will post 1.32 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Separately, StockNews.com raised Avanos Medical from a "hold" rating to a "buy" rating in a research note on Wednesday.

Avanos Medical Company Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.